Since MDM2 is the principal p53 inhibitor and it is transcriptionally activated by p53 itself, its inhibition by miR-221 establishes a miR-221/TP53 positive feed-forward loop that is essential for p53-dependent cell cycle regulation and response to anticancer treatments in HCC cells. The gene discussed is TP53; the disease is hepatocellular carcinoma.